In a special 3-part season premiere, Halteres Presents is spotlighting tuberculosis diagnostics worldwide, and where things stand in the field today. In Part One, Rich Thayer and Mickey Urdea are interviewing Dr. Morten Ruhwald, who leads the TB Programme at FIND in Geneva, Switzerland. He trained as a medical doctor at Copenhagen University Hospitals, Denmark and obtained his PhD in TB Immunology at Copenhagen University. Prior to joining FIND, Morten served as CMO and Head of Human Immunology at Statens Serum Institute of Denmark, overseeing the clinical development of the TB and chlamydia vaccine programs. Morten's research interests include molecular and immunoassay development for TB and TBI diagnostics, non-sputum-based diagnostic approaches, biomarkers, digital tools, and personalized medicine in TB.

FIND Tuberculosis Programme: https://www.finddx.org/what-we-do/programmes/tuberculosis/

World Health Organization (WHO) Global Tuberculosis Report, 2022: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022 

This episode of "Halteres Presents" is brought to you by the UC San Diego Extended Studies In Vitro Diagnostics Product Development course, a unique live-online program designed for managers, entrepreneurs, investors, and scientists. Enroll today and use our exclusive discount code HALTERES10 at checkout for 10% off the price of your enrollment. 

⁠⁠UC San Diego Extended Studies In Vitro Diagnostics Product Development Course⁠⁠

Use code: HALTERES10 at checkout!

Learn more about Halteres Associates ⁠⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠⁠.